Article Details
Retrieved on: 2024-04-23 21:27:36
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article outlines Chronic Myelogenous Leukemia (CML), a cancer diagnosed by detecting the Philadelphia chromosome, and treatments like tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, and nilotinib. Key concepts include managing CML during pregnancy and related treatment challenges due to potential effects on the fetus.
Article found on: www.medscape.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here